Overview

An Ascending Multiple Dose Study With VTP-43742 in Healthy Volunteers

Status:
Completed
Trial end date:
2016-03-08
Target enrollment:
Participant gender:
Summary
This is Part 1 of a two-part, randomized, double-blind, placebo-controlled study in which VTP-43742 was administered to participants; Part 1 in healthy volunteers and Part 2 in psoriatic participants.
Phase:
Phase 1
Details
Lead Sponsor:
Vitae Pharmaceuticals Inc., an Allergan affiliate